It’s a brand-name prescription drug used to treat chronic obstructive pulmonary disease (COPD) and asthma in adults. Trelegy Ellipta comes as a powder you inhale into your lungs using the ...

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...

Verona Pharma has claimed FDA approval for its chronic obstructive pulmonary disease (COPD) drug ensifentrine ... given the somewhat tongue-twisting brand name of Ohtuvayre – is the first ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual condition management.

"This may inform prescribing of glucose-lowering medications among patients with T2D and active COPD," making SGLT2 and GLP-1 drugs preferable over DPP-4 inhibitors for these patients, the group ...

Share on Pinterest GLP-1 and SGLT-2 drugs may be the best treatments for people with type 2 diabetes and COPD. Image credit: Visual Vic/Getty Images. Researchers estimate the number of people ...

This may inform prescribing of glucose-lowering medications among patients with type 2 diabetes and active COPD.